[头孢曲松治疗下呼吸道感染：与头孢噻肟的比较]
[Ceftriaxone in the therapy of infections of the lower respiratory tract: comparison with cefotaxime].
作者信息
Lanni N, Scaglione B
出版信息
Minerva Med. 1986 Mar 10;77(9-10):317-9.
PMID:3485265
Abstract
20 patients suffering from severe lower respiratory tract infections were included in the study. 10 patients were given ceftriaxone (1-2 g/day) and the other 10 cefotaxime (2-4 g/day) for a week. The results of microbiological findings and both local and systemic tolerance were found to be similar for both drugs. This indicates that 7-14 g of ceftriaxone and 14-28 g of cefotaxime are equivalent quantities in the treatment of severe respiratory tract infections.
摘要
20名患有严重下呼吸道感染的患者被纳入该研究。10名患者接受头孢曲松（1 - 2克/天）治疗，另外10名患者接受头孢噻肟（2 - 4克/天）治疗，为期一周。发现两种药物的微生物学检查结果以及局部和全身耐受性均相似。这表明在治疗严重呼吸道感染时，7 - 14克头孢曲松和14 - 28克头孢噻肟的疗效相当。
相似文献
1
[Ceftriaxone in the therapy of infections of the lower respiratory tract: comparison with cefotaxime].
Minerva Med. 1986 Mar 10;77(9-10):317-9.
2
Roxithromycin (RU 28965) in the treatment of respiratory tract infections.
Chemioterapia. 1987 Feb;6(1):41-4.
3
Susceptibility patterns of bacterial isolates from hospitalised patients with respiratory tract infections (MOXIAKTIV Study).
Int J Antimicrob Agents. 2009 Jan;33(1):52-7. doi: 10.1016/j.ijantimicag.2008.07.017. Epub 2008 Oct 1.
4
In vitro activity of cefditoren and other antimicrobial agents against 288 Streptococcus pneumoniae and 220 Haemophilus influenzae clinical strains isolated in Zaragoza, Spain.
Diagn Microbiol Infect Dis. 2008 Oct;62(2):210-5. doi: 10.1016/j.diagmicrobio.2008.06.007. Epub 2008 Aug 20.
5
The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
Clin Ther. 2006 Dec;28(12):2061-9. doi: 10.1016/j.clinthera.2006.12.010.
6
Comparative clinical evaluation of ceftriaxone in treating lower respiratory tract infections.
Chemioterapia. 1986 Feb;5(1):26-32.
7
Clinical evaluation of ceftriaxone.
Clin Ther. 1984;6(5):653-61.
8
[Multicentre, randomized, prospective and comparative study of ceftriaxone, cefotaxime and cefuroxime in treating mild to moderate respiratory tract infection].
Zhonghua Jie He He Hu Xi Za Zhi. 1998 Sep;21(9):528-31.
9
In vitro evaluation of cefodizime, cefuroxime, ceftriaxone against respiratory pathogens.
J Chemother. 1994 Feb;6(1):35-8. doi: 10.1080/1120009x.1994.11741126.
10
Comparison of once-daily cephalosporin regimens for community-acquired lower respiratory tract infections in patients with chronic lung disease.
Clin Ther. 1989 May-Jun;11(3):304-14.
引用本文的文献
1
Cefotaxime. An update of its pharmacology and therapeutic use.
Drugs. 1990 Oct;40(4):608-51. doi: 10.2165/00003495-199040040-00008.
Zotero 插件